| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/13/2005 | EP1077938B1 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1196704C Process for preparing inhibitors of nucleoside metabolism |
| 04/13/2005 | CN1196684C Process for producing N.N'-carbonyl dilactan |
| 04/13/2005 | CN1196679C Process for the production of amorphous atorvastatin calcium |
| 04/13/2005 | CN1196464C Novel coloring agent for use in oxidative hair dyeing |
| 04/12/2005 | US6878826 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof |
| 04/12/2005 | US6878736 Histamine H3 receptor ligands |
| 04/12/2005 | US6878732 5,7-diazaspiro(3.4)octane and -octene derivatives; treating diseases including emesis, depression, anxiety and cough |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878700 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 04/12/2005 | CA2356065C Phenoxyphenylheterocycle derivatives as ssris |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2081836C Aromatic amidine derivatives and salts thereof |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030695A1 Conversion of amine- to carboxyl groups on solid surfaces |
| 04/07/2005 | WO2004113289A3 Glycosidase inhibitors and methods of synthesizing same |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075390 HIV protease inhibitors |
| 04/07/2005 | US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds |
| 04/07/2005 | US20050075368 Solvent extracting natural E2,E4-decadienal and undecadienal from ground, dried fruit of piper species; oxidation, esterification and transamidation; taste and aroma enhancers; bactercidel, fungicide and insecticidide activity |
| 04/07/2005 | US20050075367 Ester compound and medicinal use thereof |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075320 Gamma-secretase inhibitors |
| 04/07/2005 | US20050075316 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmai agents; anticancer agents; astaxanthin |
| 04/07/2005 | US20050074748 Bioreactive agents |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/06/2005 | EP1521107A1 Filters for electronic displays |
| 04/06/2005 | EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519918A1 Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap) |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1020459B1 Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives |
| 04/06/2005 | EP0960096B1 Substituted beta-thiocarboxylic acids |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604892A Prodrugs to d-prolines |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1604776A 4-4-alkoxy-3-hydroxyphenyl-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/06/2005 | CN1195783C Polymerization of olefins |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195741C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875884 Urea derivatives as inhibitors for CCR-3 receptor |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875863 Anticancer agents |
| 04/05/2005 | US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 04/05/2005 | CA2245686C In situ block copolymer formation during polymerization of a vinyl aromatic monomer |
| 04/05/2005 | CA2226671C 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028440A1 Novel gamma secretase inhibitors |
| 03/31/2005 | WO2005028435A1 Process for preparing 2-oxo-1-pyrrolidine derivatives |
| 03/31/2005 | WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor |
| 03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| 03/31/2005 | WO2004092126B1 Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 03/31/2005 | WO2004085347A3 Production of n-aryl-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
| 03/31/2005 | US20050070722 Chemical intermediate for cephalosporin bactericides |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070593 Reacting 3-Ethyl-4-methyl-3-pyrrolidin-2-one with a haloformic aryl esters to form an intermediate, reacting intermediate with 4-(2-amino-ethyl)benzene sulfonamide to form 4-[2-(3-Ethyl-4-methyl-2-carbonyl pyrrolidine amido)ethyl]benzene sulfonamide, reacting product with 4-methylcyclohexyl isocyanate |
| 03/31/2005 | US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders |
| 03/31/2005 | US20050070552 Ion channel modulating activity I |
| 03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 03/31/2005 | US20050070521 Alkyl ether derivatives or salts thereof |
| 03/31/2005 | US20050070520 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 03/31/2005 | US20050070485 Phenylalanine derivatives |
| 03/31/2005 | US20050070482 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism |
| 03/31/2005 | US20050070480 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
| 03/31/2005 | CA2538590A1 Novel gamma secretase inhibitors |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/30/2005 | EP1517894A1 N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 03/30/2005 | EP1517893A2 Process for producing levetiracetam |
| 03/30/2005 | EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 03/30/2005 | EP1446496A4 Methods for ligand discovery |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1600772A Aryl phenyl substituted cyclic ketoenols |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872836 Converting a protected 1,4- dihydroxy-2-amino or protected amino butane in presence of hydroxylamine or an acid additon salt into N-hydroxy-pyrrolidone derivative, reducting N-hydroxy group to secondary amine by hydrogenation |
| 03/29/2005 | US6872745 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 03/29/2005 | US6872742 Antiulcer agents, vision defects, viricides, antiinflammatory agents |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/29/2005 | US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis |
| 03/29/2005 | US6872735 LFA-1 antagonist compounds |
| 03/29/2005 | CA2392879C A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 03/29/2005 | CA2268870C Heterocyclic carboxamides |
| 03/24/2005 | WO2005026373A1 Enzymatic synthesis of enatiopure intermediates by means of cholesterolesterase from yeasts |
| 03/24/2005 | WO2005026116A1 Crystalline forms of `r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-`(phenylamino)carbonyl!-1h-pyrrole-1-heptanoic acid |
| 03/24/2005 | WO2005026115A1 PROCESS FOR CONVERTING α-ANGELICA LACTONE TO 5-METHYL-N-ALKYL-2-PYRROLIDONE USING ALKYL AMINES |
| 03/24/2005 | WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
| 03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |